Probiotix Health PLC Appointment of Non-Executive Director
October 07 2024 - 1:00AM
RNS Regulatory News
RNS Number : 0564H
Probiotix Health PLC
07 October 2024
7 October 2024
ProBiotix Health
plc
("ProBiotix"
or the "Company"
or, together with its subsidiary, the "Group")
Appointment of Non-Executive
Director
ProBiotix Health plc (AQSE: PBX),
the life sciences business developing probiotics to support
cardiometabolic health, is pleased to announce that, further to the
announcement of 4 September 2024, Frederik Bruhn-Petersen has been
appointed as a Non-executive Director of the Company.
Frederik is currently working in a
managing role for Holdingselskabet af 29. Juni 2010 Aps, an
investment vehicle of the Bruhn-Petersen family, which is
interested in 33,160,000 ordinary shares in the Company,
representing 20.97% of the Company's current issued share
capital.
Frederik is an entrepreneur and is
the co-founder of RobinHus A/S, a disruptive real estate brokerage
in Denmark, driving the business from its start-up phase to a
national franchise based operator, before ultimately selling to
Denmark's largest real estate player, EDC A/S. Frederik has a
Masters of Law Degree from Copenhagen University.
Frederik is interested in 3,000,000
ordinary shares in the Company.
For further information, please
contact:
|
ProBiotix Health plc
|
https://probiotixhealth-ir.com/
|
|
Steen Andersen, Chief Executive
Officer
|
Contact via Walbrook
below
|
|
|
|
|
Peterhouse Capital Limited (Aquis Corporate Adviser and Broker)
|
Tel: 020
7220 9793
|
|
Mark Anwyl
|
|
|
|
|
|
Walbrook PR Ltd
|
probiotix@walbrookpr.com
or 07876 741
001
|
|
Anna Dunphy
|
|
|
|
|
| |
Save as set out below,
there is no further information regarding Frederik
Bruhn-Petersen that is required to be disclosed pursuant to Rule
4.9 of the Aquis Growth Market Access Rulebook.
CURRENT
DIRECTORSHIPS
VICS 6998 ApS
HCS 82 ApS
K/S BAXTERGATE
(DONCASTER)
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact
rns@lseg.com or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our
Privacy
Policy.
END
NEXMZMGGKDFGDZM
Probiotix Health (AQSE:PBX)
Historical Stock Chart
From Nov 2024 to Dec 2024
Probiotix Health (AQSE:PBX)
Historical Stock Chart
From Dec 2023 to Dec 2024
